Genta

Biotech Stock Mailbag: Bio-Hazards
The Street
Sat, 03/26/11 - 10:00 am
Telik
Xoma
Genta
Cell Therapeutics
Discovery Labs
Cel-Sci
Pooled Results of Early Endpoints from Phase 3 Trials of Genasense® in Advanced Melanoma Presented at ASCO
Yahoo/BusinessWire
Sun, 06/6/10 - 10:51 am
Genta
melanoma
Genasense
Allon, Genta programs win FDA fast-track status
Fierce Biotech
Wed, 04/7/10 - 10:19 am
FDA
Genta
Allon Therapeutics
fast track
Tesetaxel
davunetide
Genta starts phase-2 trial of oncology product Tesetaxal
Pharmabiz
Sat, 02/27/10 - 01:17 pm
Genta
Tesetaxel
cancer
tubulin inhibitor
Has Genta's Energizer Bunny of Cancer Drugs Finally Run Out of Juice?
BNET Pharma
Thu, 11/5/09 - 08:50 am
Genta
cancer
Genasense
Genta Melanoma Drug Study Disappoints
TheStreet.com
Thu, 10/29/09 - 09:03 am
Genta
melanoma
drug study
Genta Announces Closing of $10 Million in Two Offerings of Common Stock and Convertible Notes
Yahoo/BusinessWire
Sun, 09/6/09 - 01:01 pm
Genta
Hot Biotech Events for Next Week: BioBuzz
TheStreet.com
Fri, 09/4/09 - 08:49 am
biotech
Elan
Geron
Cell Therapeutics
Genta
Antigenics
Vivus
Osiris Therapeutics